Free tool
FAERS Monitor: Saphris
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 022117 or its brand name (Saphris, Asenapine Maleate). Reports on generic versions are filed under their own applications.
Reports
7,825
Serious
3,466
44% of reports
Hospitalization
1,144
Death reported
279
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective806
- sedation667
- suicide attempt651
- inappropriate schedule of drug administration557
- weight increased537
- dyskinesia520
- dystonia496
- blood glucose increased477
- sexual dysfunction427
- anosognosia423
- blood prolactin abnormal413
- metabolic disorder413
- disturbance in social behaviour410
- akathisia398
- personality change385
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2009 | 17 |
| 2010 | 1,716 |
| 2011 | 1,017 |
| 2012 | 1,003 |
| 2013 | 1,397 |
| 2014 | 197 |
| 2015 | 152 |
| 2016 | 279 |
| 2017 | 215 |
| 2018 | 206 |
| 2019 | 306 |
| 2020 | 241 |
| 2021 | 265 |
| 2022 | 288 |
| 2023 | 232 |
| 2024 | 111 |
| 2025 | 109 |
| 2026 | 74 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,334 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| anosognosiaSignal | 423 | 3297.7 | 2865.6 | 624,793 |
| blood prolactin abnormalSignal | 413 | 2468.5 | 2163.9 | 529,900 |
| disturbance in social behaviourSignal | 410 | 566.1 | 510.1 | 190,619 |
| metabolic disorderSignal | 413 | 205.7 | 186.6 | 77,987 |
| personality changeSignal | 385 | 116.2 | 105.2 | 42,046 |
| sexual dysfunctionSignal | 427 | 101.5 | 92.4 | 40,889 |
| akathisiaSignal | 398 | 80.7 | 73.2 | 30,366 |
| dystoniaSignal | 496 | 70.5 | 64.7 | 33,084 |
| sedationSignal | 667 | 70.2 | 65.2 | 44,340 |
| dyskinesiaSignal | 520 | 34.8 | 32.0 | 16,864 |
| suicide attemptSignal | 651 | 29.2 | 27.1 | 17,537 |
| inappropriate schedule of drug administrationSignal | 557 | 21.2 | 19.6 | 10,655 |
| blood glucose increasedSignal | 477 | 6.8 | 6.3 | 2,378 |
| weight increasedSignal | 537 | 6.5 | 6.0 | 2,493 |
| drug ineffective | 806 | 1.6 | 1.5 | 216 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.